BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $111 at Barclays
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $64.06 +0.19%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Barclays analyst Eliana Merle raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $111.00 (from $105.00) while maintaining a Overweight rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $97 at BMO Capital
- Shift4 Payments (FOUR) PT Lowered to $56 at StoneX as Iran War Impacts Revenues
- Lithia Motors (LAD) PT Lowered to $409 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
